ArticleBMC health services research2025
Knowledge, attitude, and practice of pharmacovigilance among healthcare professionals at a tertiary level hospital, Sudan: a cross sectional study.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdverse drug reactions (ADRs) are a significant cause of morbidity and mortality worldwide, reflecting a critical need for effective pharmacovigilance. Pharmacovigilance ensures drug safety by monitoring, assessing, and preventing the occurrence of ADRs. Healthcare professionals are pivotal in this system because of their interactions with patients and medications. Understanding their knowledge, attitudes, and practices toward pharmacovigilance is crucial for identifying gaps and enhancing initiatives for drug safety.
objectiveTo evaluate the knowledge, attitudes, and practices of pharmacovigilance among healthcare professionals at Atbara Teaching Hospital, identify the reasons for the underreporting of ADRs, and determine if there is a significant association between pharmacovigilance training and ADR reporting.
methodsThis descriptive cross-sectional study was conducted at Atbara Teaching Hospital via a stratified simple random sampling method. Data was collected using a self-administered questionnaire consisting of demographic data and a knowledge, attitude, and practice section. The data were analyzed via the Statistical Package for Social Sciences (SPSS) to determine associations between various variables.
resultsA total of 122 healthcare professionals participated in the study. The knowledge of pharmacovigilance among the participants was moderate, with a mean knowledge score of 5.1 ± 1.9 out of 12. The definition and primary purpose of pharmacovigilance were correctly identified by 67.2% and 69.7%, respectively, and the definition of adverse drug reaction was identified by 54.1%. Notably, only 23.8% were aware of the existence of pharmacovigilance program in Sudan. The participants showed a generally positive attitude toward pharmacovigilance with a mean score of 7.7 ± 2.0 out of 12. A total of 95.1%, agreed with the necessity of ADR reporting and 79.5% believed that pharmacovigilance should be taught to all healthcare professionals. The practice of ADR reporting was lacking; although 66.4% of the participants had observed an ADR during their professional practice, only 18.9% reported it. This imbalance between the ADR observed and reported was attributed to several barriers, mainly due to unawareness of how and where to report an ADR and the lack of incentives for reporting. The study revealed a significant association between pharmacovigilance training and ADR reporting.
conclusionsWhile healthcare professionals exhibited adequate knowledge, and favourable attitudes toward pharmacovigilance, practical reporting rates were low. Targeted training, streamlined reporting mechanisms, and policy interventions are recommended to bridge this gap and enhance drug safety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.